Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (Details)

v3.6.0.2
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Basic and diluted numerator:        
Net loss available to iBio, Inc. stockholders $ (3,229) $ (2,246) $ (6,290) $ (4,051)
Basic and diluted denominator:        
Weighted-average common shares outstanding 89,109 77,326 89,109 77,316
Per share amount $ (0.04) $ (0.03) $ (0.07) $ (0.05)